Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Amish Raval Added: 1 year ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more
Author(s): Milind Y Desai Added: 1 year ago
ACC 2025 - First-in-human results from MyPEAK-1 show Tn-201 treatment in adults with Mybpc3-associated hypertropic cardiomyopathy was feasible and safe.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at ACC 2025 to discuss phase Ib/2a results from the first-in-human, non-randomized study investigating the safety and early efficacy of Tn-201, an adeno-associated virus serotype 9 gene… View more
Job title: Research Fellow
Personal History Dr Agnieszka Kotalczyk is a cardiologist-in-training from Poland. Academic History She obtained her Medical Degree from the Medical University of Silesia, Katowice, Poland. Career Overview Dr Kotalczyk is a Research Fellow at the Liverpool Centre for Cardiovascular Science and Liverpool Heart and Chest Hospital. She is also a Cardiology Trainee at the… View more
Job title: Lead, Cardiology
Dr Sayan Sen leads the Imperial College Healthcare NHS Trust cardiology service for central and west London. Dr Sen studied medicine at University College London (UCL), achieving a first class (honours) BSc degree in medical sciences and neuroscience in 2000. He graduated with distinction in his final MBBS examinations in 2003. Dr Sen's academic awards include the Royal Society of Medicine… View more
Job title: PhD
Gary E Raskob's research and scholarly interests are in the prevention, diagnosis and treatment of deep-vein thrombosis and pulmonary embolism; the clinical development of antithrombotic drugs; clinical trials; prevention research; evidence-based medicine; and the translation of research evidence into practice and health policy. Gary E Raskob has participated extensively in clinical practice… View more